Suppression of inner blood-retinal barrier breakdown and pathogenic Müller glia activation in ischemia retinopathy by myeloid cell depletion
Journal of Neuroinflammation,
Год журнала:
2024,
Номер
21(1)
Опубликована: Авг. 24, 2024
Abstract
Ischemic
retinopathies
including
diabetic
retinopathy
are
major
causes
of
vision
loss.
Inner
blood-retinal
barrier
(BRB)
breakdown
with
retinal
vascular
hyperpermeability
results
in
macular
edema.
Although
dysfunction
the
neurovascular
unit
neurons,
glia,
and
cells
is
now
understood
to
underlie
this
process,
there
a
need
for
fuller
elucidation
underlying
events
BRB
ischemic
disease,
systematic
analysis
myeloid
exploration
cellular
cross-talk.
We
used
an
approach
microglia
depletion
CSF-1R
inhibitor
PLX5622
(PLX)
ischemia-reperfusion
(IR)
model.
Under
non-IR
conditions,
PLX
treatment
successfully
depleted
retina.
suppressed
microglial
activation
response
following
IR
as
well
infiltration
monocyte-derived
macrophages.
This
occurred
association
reduction
expression
chemokines
CCL2
inflammatory
adhesion
molecule
ICAM-1
.
In
addition,
was
marked
suppression
neuroinflammation
IL-1b
,
IL-6
Ptgs2
TNF-a
Angpt2
protein
that
regulates
permeability.
significantly
inner
IR,
without
appreciable
effect
on
neuronal
dysfunction.
A
translatomic
Müller
glial-specific
gene
vivo
using
Ribotag
demonstrated
strong
cell
multiple
pro-inflammatory
genes
treatment.
Co-culture
studies
activated
directly
upregulates
cell-expression
these
genes,
indicating
downstream
effector
IR.
two
types
endothelial
ability
both
compromise
EC
function.
Interestingly,
quiescent
enhanced
function
co-culture
system.
Together
demonstrates
pivotal
role
setting
ischemia-associated
disease
indicates
play
iBRB
dysregulation,
through
direct
indirect
effects,
while
glia
participate
amplifying
neuroinflammatory
cells.
Язык: Английский
Role of inflammation in a rat model of radiation retinopathy
Journal of Neuroinflammation,
Год журнала:
2024,
Номер
21(1)
Опубликована: Июнь 24, 2024
Abstract
Radiation
retinopathy
(RR)
is
a
major
side
effect
of
ocular
tumor
treatment
by
plaque
brachytherapy
or
proton
beam
therapy.
RR
manifests
as
delayed
and
progressive
microvasculopathy,
ischemia
macular
edema,
ultimately
leading
to
vision
loss,
neovascular
glaucoma,
and,
in
extreme
cases,
secondary
enucleation.
Intravitreal
anti-VEGF
agents,
steroids
laser
photocoagulation
have
limited
effects
on
RR.
The
role
retinal
inflammation
its
contribution
the
microvascular
damage
occurring
remain
incompletely
understood.
To
explore
cellular
vascular
events
after
irradiation,
we
analyzed
their
time
course
at
1
week,
month
6
months
rat
eyes
received
45
Gy
X-beam
photons.
Müller
glial
cells,
astrocytes
microglia
were
rapidly
activated,
these
markers
persisted
for
irradiation.
This
was
accompanied
early
cell
death
outer
retina,
which
later
points,
thinning.
A
loss
small
capillaries
hypoxia
observed
months,
indicating
inner
blood‒retinal
barrier
(BRB)
alteration
but
without
retina.
Moreover,
activated
microglial
cells
invaded
entire
retina
surrounded
vessels,
suggesting
death.
also
triggered
persistent
invasion
pigment
epithelium
macrophages,
contributing
BRB
disruption.
study
highlights
long-lasting
inflammatory
mechanisms
development
demonstrates
relevance
this
model
investigate
human
pathology.
Язык: Английский
Ganoderma lucidum polysaccharide attenuates retinal ischemia-reperfusion injury by regulating microglial M1/M2 polarization, suppressing neuroinflammation and inhibiting JAK2/STAT3 pathway
Biochemistry and Biophysics Reports,
Год журнала:
2025,
Номер
41, С. 101926 - 101926
Опубликована: Янв. 29, 2025
Язык: Английский
Current Opportunities and Future Prospects of Neuroprotective Therapy in Glaucoma. Literature Review. Part 1
Ophthalmology in Russia,
Год журнала:
2025,
Номер
22(1), С. 5 - 15
Опубликована: Март 28, 2025
This
literature
review
is
devoted
to
one
of
the
most
complex
ophthalmology
problems
—
neuroprotective
and
neuroregenerative
treatment
glaucoma
consists
two
parts.
The
first
part
considers
main
mechanisms
neurodegeneration
aspects
therapeutic
control
related
these
(excitotoxicity,
mitochondrial
dysfunction,
oxidative
stress).
aim
conducted
analysis
provide
a
comprehensive
overview
both
existing
strategies
promising
areas
therapy
based
on
agents
in
potential
glaucoma.
A
wide
range
approaches
neuroprotection
demonstrates
great
for
effective
order
preserve
visual
functions
patients
with
Язык: Английский
Study on the Protective Effects and Mechanisms of Atorvastatin in Retinal Ischemia-Reperfusion Injury in Mice
Опубликована: Янв. 1, 2025
Язык: Английский
Roflumilast Attenuates Microglial Senescence and Retinal Inflammatory Neurodegeneration Post Retinal Ischemia Reperfusion Injury Through Inhibiting NLRP3 Inflammasome
Chunlian Ou,
Yi‐Wei Lin,
Jing Wen
и другие.
Investigative Ophthalmology & Visual Science,
Год журнала:
2024,
Номер
65(12), С. 38 - 38
Опубликована: Окт. 24, 2024
Retinal
ischemia-reperfusion
(RIR)
injury
is
implicated
in
various
retinal
diseases,
leading
to
ganglion
cells
(RGCs)
degeneration.
Microglial
senescence
exacerbates
inflammation,
contributing
neurodegeneration.
This
study
aimed
investigate
the
potential
therapeutic
role
of
Roflumilast
(Roflu)
ameliorating
microglial
and
neuroinflammation
following
RIR
injury.
Язык: Английский